Email Updates

You are here

AVAC in the News

  • This week the world has been looking back at 30 years of AIDS. Three decades have taken us from five young gay men in Los Angeles to 34 million men, women and children around the world living with HIV. But what about the next thirty years? Could we see an end to AIDS?

    June 9, 2011
    Huffington Post
  • In Kenya, clinical trials began on two promising new designs for preventive HIV vaccines. In South Africa, researchers launched clinical trials on a therapeutic vaccine intended to strengthen the immune systems of people living with HIV/AIDS.

    May 26, 2011
  • Last week the AIDS world received the stunningly encouraging results of an advanced-stage clinical trial known as “HPTN 052.”

    May 19, 2011
  • Millions of HIV infections could be averted by treating patients earlier than current guidelines recommend, after a study showed giving pills to patients as soon as they’re diagnosed can prevent them infecting others.

    May 13, 2011
  • The journal Science chose an AIDS study as the twenty-eleven "Breakthrough of the Year." The study found that antiretroviral drugs can greatly lower the risk of spreading HIV, the virus that causes AIDS. It showed that infected people with early treatment were ninety-six percent less likely to infect their partners.

    January 10, 2011
    Voice of America
  • To ensure that high-level promises are kept and to get the funding we need to effectively implement the tenets of the National HIV/AIDS Strategy, we need our A-list soldiers on the line. In that spirit, we offer the following list of 100 people we feel have great impact on HIV/AIDS in the United States today. We have many of them to thank for the progress we’ve recently made. These people are also likely to keep the heat on in the months and years to come.

    December 31, 2010
  • For the first time, a microbicide gel -- a product that could be used by women -- had been shown to reduce the risk of acquiring HIV.

    December 23, 2010
    MedPage Today
  • Last week, 2,499 gay and bisexual men and transgender women from four continents made history when the iPrEx HIV prevention trial reported positive results.

    December 10, 2010
    Huffington Post
  • In the study, published Tuesday by the New England Journal of Medicine, researchers found that the men taking Truvada, a common combination of two antiretroviral drugs, were 44 percent less likely to get infected with the virus that causes AIDS than an equal number taking a placebo.

    November 23, 2010
    New York Times
  • In the next few months, said Mitchell Warren, executive director of AVAC, an advocacy group for AIDS prevention, “we’re going to see a cascade of results” from trials of what is called “oral pre-exposure prophylaxis,” or “oral prep” for short. In them, men and women who are not infected with the AIDS virus but who regularly engage in high-risk sex, like anal sex without condoms or sex for money with strangers, take a daily dose of one or two of the antiretroviral drugs normally taken by infected people.

    November 8, 2010
    New York Times